What we believe
Digital health startups offer high returns and impact and can improve millions of lives. However, with only about 2% chance of success, most digital health startups fail due to their business model. There are many risks related to fundraising, go to market, building partnerships etc. and too many decisions are often made on gut feelings due to time and resource constraints.
At Accelerace, we remove those risks by helping you focus your time and resources on critical issues and prioritizing and de-risking your project using personalized issue trees and lean/agile business models. We provide open office hours and sparing for our founders based on over 100 years of collective entrepreneurial experience and using bespoke coaching tools & techniques built by founders for founders.
Through our Nordic Mentor Network for Entrepreneurship (NOME) collaboration, we also offer immediate access to world-class mentors and key opinion leaders.
Our portfolio of digital health startups
The Cardiosynchrogram provides technology which can improve patient selection and treatment for a specific type of heart failure – an area where currently up to 40% of recipients do not benefit from treatment. The technology is an algorithm that analyzes standard clinical 12-lead ECG recordings and measures and visualizes (dys)synchrony in the electrical activation of the heart chambers.
MagCath developed a single-use, very soft, silicone tube, that the user herself inserts in the urethra each morning. The tube stays in place all day, and has an inner valve, which restores control over bladder voiding.
Cobo Technologies is a biomedical technology company that develops new services and products within the CRISPR/Gene Editing field.
Photologics is an app solution for plastic surgeons and other medical professionals to record, store and categorize patient photographs, which are used for planning surgeries, documentation and patient information. The solution allows quick and easy access and a more fluid way to manage patient photography.
RowAnalytics is an AI solutions company innovating high dimensional, hyper-combinatorial data analytics to solve grand challenges in health, food and smart living. RowAnalytics’ innovative tools enable the personalization at scale required to deliver next-generation precision medicine, digital health and smart IoT solutions, with exciting potential in the field of precision agriculture.
Aglance Solutions is advancing the communication and documentation of health symptoms through the development of a digital body mapping and pain tracking software.
What you get
A unique chance to profit from our unique network
As a part of the program you not only get the opportunity to shape your businesses in the accelerator, the most promising startups even have the chance to join the NOME network. The Nordic Mentor Network for Entrepreneurship (NOME) is a mentoring program with world-class mentors which matches Nordic projects and startups with highly skilled volunteer professionals to help them reach their goals and technology milestones.
As a part of the program, NOME also provides a unique platform for startups to participate in a boot camp in the US. There, the projects get access to FDA experts and contacts to on-site representatives. With inspiration from MIT Venture Mentoring Service, the vision of NOME is to develop and implement a best-in-class mentoring initiative that will propel the Nordic countries into one of the leading life science regions to commercialize high growth life science startups.
“The program has helped us to identify and focus on the most important thing for HelloMind at our current stage of growth. It has been extremely helpful that Accelerace has put together a diversified team of experts both inhouse and external to support us as an early-stage startup. Also, it is worth mentioning that the program is not a 'standard' program, but has been adjusted to our needs along with some added great learning seminars. We feel confident and excited.”
CEO and founder of HelloMind
“Accelerace helped us at a critical early-stage financing. This meant that we were able to finish our pilot study and raise an investment. With this investment, we could initiate our large scale randomized clinic study, and obtain evidence that our treatment can help the patients. The study has just been completed and currently we are busy bringing our LeucoPatch product to the market to help patients heal chronic wounds, like diabetic foot ulcers. We are happily looking back to our time in Accelerace.”
Chief Operating Officer, Reapplix
"In the beginning of the accelerator, we had a workshop where we got a thorough review of our past major decisions (e.g. what we have done and why). It was a good retrospective to form a base for future decisions. We are now forming stepping stones and a roadmap on what is needed for a complete scalable business model."
At the Novo Nordisk Foundation, we are very pleased with the Nordic Mentor Network for Entrepreneurship (NOME) that Accelerace has established over the last year. Today NOME covers the entire Nordic region including life science start-ups from all Nordic countries and several high-level mentors in the network. NOME is surely on its way to become the beacon in the ecosystem that we had hoped for from the very beginning.
Head of Operations, Novo Nordisk Foundation